Concerning the alteration of metabolic pathways, some reports indicate that NSCLC cells mutant for KRAS and STK11 become dependent on hexosamine biosynthesis and de novo fatty acid synthesis. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.